UBS raises Axsome Therapeutics stock price target to $133
UBS analysts increased the price target on Axsome Therapeutics (NASDAQ:AXSM) shares to $133.00, up from the previous $105.00, while maintaining a Buy rating on the stock. The company, currently valued ...
This $1 Billion Taiwanese-American UBS Advisor Thrives With A First Generation Team
Diane Hart built her practice as a sole practitioner by connecting with Asian American clients and leveraging her unique cultural perspective.
UBS’s stock got clobbered after earnings. Deutsche Bank says it’s now a buy.
UBS’s stock is now worth buying, after tumbling following the Swiss banking giant’s fourth-quarter earnings report, Deutsche ...
UBS Remains a Hold on Siemens Healthineers AG (SEMHF)
UBS analyst Graham Doyle maintained a Hold rating on Siemens Healthineers AG (SEMHF – Research Report) today and set a price target of €53.00.
Deutsche Bank lifts UBS stock rating to buy, raises target to CHF37
Deutsche Bank (ETR:DBKGn) analyst Benjamin Goy upgraded UBS AG (UBSG:SW) (NYSE: UBS) stock rating from Hold to Buy and increased the price target from CHF29.00 to CHF37.00. Goy noted that UBS's share ...
UBS Sticks to Its Buy Rating for Soitec SA (0RMT)
UBS analyst Francois Xavier Bouvignies maintained a Buy rating on Soitec SA (0RMT – Research Report) today and set a price target of €105.00.